NCT01773187 2020-09-29Pacritinib Versus Best Available Therapy to Treat MyelofibrosisCTI BioPharmaPhase 3 Terminated327 enrolled 11 charts
NCT01010217 2020-03-25Mismatched Transplantation Using High-dose Post-transplant CyclophosphamideM.D. Anderson Cancer CenterPhase 2 Completed176 enrolled 18 charts
NCT03195010 2019-10-21Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaFred Hutchinson Cancer CenterPhase 2 Terminated4 enrolled 13 charts
NCT01191749 2017-05-09Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)M.D. Anderson Cancer CenterPhase 2 Terminated7 enrolled 6 charts
NCT01461538 2016-03-04Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous MalignanciesSeagen Inc.Phase 2 Completed84 enrolled 20 charts
NCT00790452 2011-12-08Aspirin Prophylaxis for Venous Thromboembolism in GlioblastomaM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 1 chart